Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

Nasim Mavaddat¹, Antonis C Antoniou², Thea M Mooij³, Maartje J Hooning⁴, Bernadette A Heemskerk-Gerritsen⁴; GENEPSO; Catherine Noguès⁵, Marion Gauthier-Villars⁶, Olivier Caron⁷, Paul Gesta⁸, Pascal Pujol⁹, Alain Lortholary¹⁰; EMBRACE; Daniel Barrowdale², Debra Frost², D Gareth Evans¹¹, Louise Izatt¹², Julian Adlard¹³, Ros Eeles¹⁴, Carole Brewer¹⁵, Marc Tischkowitz¹⁶, Alex Henderson¹⁷, Jackie Cook¹⁸, Diana Eccles¹⁹; HEBON; Klaartje van Engelen²⁰, Marian J E Mourits²¹, Margreet G E M Ausems²², Linetta B Koppert²³, John L Hopper²⁴, Esther M John²⁵, Wendy K Chung^{26

27}, Irene L Andrulis^{28

29}, Mary B Daly³⁰, Saundra S Buys³¹; kConFab Investigators; Javier Benitez³², Trinidad Caldes³³, Anna Jakubowska^{34

35}, Jacques Simard³⁶, Christian F Singer³⁷, Yen Tan³⁷, Edith Olah³⁸, Marie Navratilova³⁹, Lenka Foretova³⁹, Anne-Marie Gerdes⁴⁰, Marie-José Roos-Blom³, Flora E Van Leeuwen³, Brita Arver^{41

42}, Håkan Olsson⁴², Rita K Schmutzler^{43

44}, Christoph Engel⁴⁵, Karin Kast^{46

47

48}, Kelly-Anne Phillips^{24

49

50}, Mary Beth Terry^{27

51}, Roger L Milne^{24

52

53}, David E Goldgar⁵⁴, Matti A Rookus³, Nadine Andrieu^{55

56

57

58}, Douglas F Easton^{2

59}; IBCCS, kConFab and BCFR

Affiliations

¹ Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, CBI 8RN, UK. nm274@medschl.cam.ac.uk.
² Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, CBI 8RN, UK.
³ Department of Epidemiology, Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands.
⁴ Department of Medical Oncology, Family Center Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
⁵ DASC, Oncogénétique Clinique, Institut Paoli-Calmettes, Marseille, France.
⁶ Institut Curie, Service de Génétique, Paris, France.
⁷ Département de Médecine Oncologique, Gustave Roussy Hôpital Universitaire, Villejuif, France.
⁸ Centre Hospitalier, Service Régional d'Oncologie Génétique Poitou-Charentes, Niort, France.
⁹ Unité d'Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France.
¹⁰ Centre Catherine de Sienne, Service d'Oncologie Médicale, Nantes, France.
¹¹ Genomic Medicine, Manchester Academic Health Sciences Centre, Division of Evolution and Genomic Sciences, Manchester University, Central Manchester, University Hospitals NHS Foundation Trust, Manchester, UK.
¹² Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
¹³ Yorkshire Regional Genetics Service, Chapel Allerton Hospital and University of Leeds, Leeds, UK.
¹⁴ Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.
¹⁵ Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, UK.
¹⁶ Academic Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK.
¹⁷ Institute of Genetic Medicine, Centre for Life, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK.
¹⁸ Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK.
¹⁹ University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK.
²⁰ Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
²¹ Department of Gynaecological Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
²² Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
²³ Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
²⁴ Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, 3010, Australia.
²⁵ Department of Medicine and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
²⁶ Departments of Pediatrics and Medicine, Columbia University Medical Center, New York, NY, USA.
²⁷ Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA.
²⁸ Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
²⁹ Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
³⁰ Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
³¹ Department of Medicine, Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT, USA.
³² Human Genetics Group and Genotyping Unit, CEGEN, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
³³ Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, CIBERONC (ISCIII), Madrid, Spain.
³⁴ Department of Genetics and Pathology, Pomeranian Medical University, Unii Lubelskiej 1, Szczecin, Poland.
³⁵ Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Unii Lubelskiej 1, Szczecin, Poland.
³⁶ Genomics Center, Centre Hospitalier Universitaire de Québec, Université Laval Research Center, 2705 Laurier Boulevard, Quebec City, Quebec, Canada.
³⁷ Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, A 1090, Vienna, Austria.
³⁸ Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
³⁹ Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Zluty kopec 7, 65653, Brno, Czech Republic.
⁴⁰ Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
⁴¹ The Department of Oncology and Pathology, Karolinska Institute, 171 76, Stockholm, Sweden.
⁴² Department of Oncology, Lund University Hospital, Lund, Sweden.
⁴³ Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
⁴⁴ Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
⁴⁵ Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
⁴⁶ Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
⁴⁷ National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.
⁴⁸ German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁴⁹ The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
⁵⁰ Department of Medical Oncology Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St, East Melbourne, Victoria, 8006, Australia.
⁵¹ Department of Epidemiology, Columbia University, New York, NY, USA.
⁵² Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
⁵³ Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
⁵⁴ Department of Dermatology, University of Utah School of Medicine, 30 North 1900 East, SOM 4B454, Salt Lake City, UT, 841232, USA.
⁵⁵ INSERM, U900, Paris, France.
⁵⁶ Institut Curie, Paris, France.
⁵⁷ Mines Paris Tech, Fontainebleau, France.
⁵⁸ PSL Research University, Paris, France.
⁵⁹ Centre for Cancer Genetic Epidemiology, Department of Oncology, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, CBI 8RN, UK.

PMID: 32102695
PMCID: PMC7045606
DOI: 10.1186/s13058-020-01259-w

Published Erratum

Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

Nasim Mavaddat et al. Breast Cancer Res. 2020.

. 2020 Feb 26;22(1):25.

doi: 10.1186/s13058-020-01259-w.

Authors

Affiliations

¹ Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, CBI 8RN, UK. nm274@medschl.cam.ac.uk.
² Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, CBI 8RN, UK.
³ Department of Epidemiology, Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands.
⁴ Department of Medical Oncology, Family Center Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
⁵ DASC, Oncogénétique Clinique, Institut Paoli-Calmettes, Marseille, France.
⁶ Institut Curie, Service de Génétique, Paris, France.
⁷ Département de Médecine Oncologique, Gustave Roussy Hôpital Universitaire, Villejuif, France.
⁸ Centre Hospitalier, Service Régional d'Oncologie Génétique Poitou-Charentes, Niort, France.
⁹ Unité d'Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France.
¹⁰ Centre Catherine de Sienne, Service d'Oncologie Médicale, Nantes, France.
¹¹ Genomic Medicine, Manchester Academic Health Sciences Centre, Division of Evolution and Genomic Sciences, Manchester University, Central Manchester, University Hospitals NHS Foundation Trust, Manchester, UK.
¹² Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
¹³ Yorkshire Regional Genetics Service, Chapel Allerton Hospital and University of Leeds, Leeds, UK.
¹⁴ Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.
¹⁵ Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, UK.
¹⁶ Academic Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK.
¹⁷ Institute of Genetic Medicine, Centre for Life, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK.
¹⁸ Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK.
¹⁹ University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK.
²⁰ Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
²¹ Department of Gynaecological Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
²² Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
²³ Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
²⁴ Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, 3010, Australia.
²⁵ Department of Medicine and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
²⁶ Departments of Pediatrics and Medicine, Columbia University Medical Center, New York, NY, USA.
²⁷ Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA.
²⁸ Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
²⁹ Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
³⁰ Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
³¹ Department of Medicine, Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT, USA.
³² Human Genetics Group and Genotyping Unit, CEGEN, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
³³ Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, CIBERONC (ISCIII), Madrid, Spain.
³⁴ Department of Genetics and Pathology, Pomeranian Medical University, Unii Lubelskiej 1, Szczecin, Poland.
³⁵ Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Unii Lubelskiej 1, Szczecin, Poland.
³⁶ Genomics Center, Centre Hospitalier Universitaire de Québec, Université Laval Research Center, 2705 Laurier Boulevard, Quebec City, Quebec, Canada.
³⁷ Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, A 1090, Vienna, Austria.
³⁸ Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
³⁹ Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Zluty kopec 7, 65653, Brno, Czech Republic.
⁴⁰ Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
⁴¹ The Department of Oncology and Pathology, Karolinska Institute, 171 76, Stockholm, Sweden.
⁴² Department of Oncology, Lund University Hospital, Lund, Sweden.
⁴³ Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
⁴⁴ Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
⁴⁵ Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
⁴⁶ Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
⁴⁷ National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.
⁴⁸ German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁴⁹ The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
⁵⁰ Department of Medical Oncology Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St, East Melbourne, Victoria, 8006, Australia.
⁵¹ Department of Epidemiology, Columbia University, New York, NY, USA.
⁵² Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
⁵³ Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
⁵⁴ Department of Dermatology, University of Utah School of Medicine, 30 North 1900 East, SOM 4B454, Salt Lake City, UT, 841232, USA.
⁵⁵ INSERM, U900, Paris, France.
⁵⁶ Institut Curie, Paris, France.
⁵⁷ Mines Paris Tech, Fontainebleau, France.
⁵⁸ PSL Research University, Paris, France.
⁵⁹ Centre for Cancer Genetic Epidemiology, Department of Oncology, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, CBI 8RN, UK.

PMID: 32102695
PMCID: PMC7045606
DOI: 10.1186/s13058-020-01259-w

Abstract

After publication of the original article [1], we were notified that columns in Table 2 were erroneously displayed.

PubMed Disclaimer

Erratum for

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
Mavaddat N, Antoniou AC, Mooij TM, Hooning MJ, Heemskerk-Gerritsen BA; GENEPSO; Noguès C, Gauthier-Villars M, Caron O, Gesta P, Pujol P, Lortholary A; EMBRACE; Barrowdale D, Frost D, Evans DG, Izatt L, Adlard J, Eeles R, Brewer C, Tischkowitz M, Henderson A, Cook J, Eccles D; HEBON; van Engelen K, Mourits MJE, Ausems MGEM, Koppert LB, Hopper JL, John EM, Chung WK, Andrulis IL, Daly MB, Buys SS; kConFab Investigators; Benitez J, Caldes T, Jakubowska A, Simard J, Singer CF, Tan Y, Olah E, Navratilova M, Foretova L, Gerdes AM, Roos-Blom MJ, Van Leeuwen FE, Arver B, Olsson H, Schmutzler RK, Engel C, Kast K, Phillips KA, Terry MB, Milne RL, Goldgar DE, Rookus MA, Andrieu N, Easton DF; IBCCS; kConFab; BCFR. Mavaddat N, et al. Breast Cancer Res. 2020 Jan 16;22(1):8. doi: 10.1186/s13058-020-1247-4. Breast Cancer Res. 2020. PMID: 31948486 Free PMC article.

References

1. Mavaddat, et al. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2020;22:8. doi: 10.1186/s13058-020-1247-4. - DOI - PMC - PubMed

Publication types

Actions

Grants and funding

UL1 TR001863/TR/NCATS NIH HHS/United States

LinkOut - more resources

Full Text Sources
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

Affiliations

Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

Authors

Affiliations

Abstract

Erratum for

References

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources

Miscellaneous